['p73 and p63 are two structural and functional homologs of p53, and their biological functions in cancer progression have attracted attention due to the presence of variants generated by genetic polymorphisms. Recently, three single nucleotide polymorphisms (SNPs) in the p63 and p73 genes have been associated with female reproduction. In the present study, we aimed to evaluate the relationship between these SNPs and ovarian cancer susceptibility and clinical pathology.', 'We genotyped the p63 (rs873330 [Genbank, refSNP ID] T\u2009>\u2009C [T: original base, C: mutant base]) and p73 (rs4648551 G\u2009>\u2009A and rs6695978 G\u2009>\u2009A) SNPs in ovarian cancers and healthy controls and analyzed the distributions of genotype frequencies to evaluate the association of the genotypes with the risk of ovarian cancer and the clinicopathological characteristics. Logistic regression models were applied in statistical analyses.', 'Our research revealed that p73 rs6695978 G\u2009>\u2009A was significantly associated with ovarian cancer patients. Women with the A allele were at increased risk of ovarian cancer compared to carriers of the G allele (OR\u2009=\u20091.55; 95% CI:1.07-2.19; P\u2009=\u20090.003). Meanwhile, the at-risk A allele was positively related with the occurrence of mucinous ovarian cancer (OR\u2009=\u20093.48; 95% CI:1.15-6.83; P\u2009=\u20090.001), low degree of differentiation (OR\u2009=\u20091.87; 95% CI:1.03-3.47; P\u2009=\u20090.003), lymph node metastasis (OR\u2009=\u20091.69; 95% CI: 1.14-2.75; P\u2009=\u20090.010) and estrogen receptor positive (OR\u2009=\u20092.72; 95% CI: 1.38-4.81; P\u2009=\u20090.002). However, we were unable to find any associations of the polymorphisms in another two SNPs (rs4648551 G\u2009>\u2009A, rs873330 T\u2009>\u2009C) with ovarian cancer risk and clinicopathological parameters.'] Are polymorphisms in the p63 and p73 genes associated with ovarian cancer risk and clinicopathological variables?